Publications by authors named "Yolanda Alcorta"

Claim this Profile
I
Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection.
Emilie Goguet, Cara H Olsen, William A Meyer, Sara Ansari, John H Powers, Yolanda Alcorta

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability.
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, Cara Olsen, Emilie Goguet, Yolanda Alcorta

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin Swabbing for Staphylococcus aureus-Targeting Phages.
Christopher Duplessis, Thomas C Luke, Chase Watters, Yolanda Alcorta, Biswajit Biswas

Mil Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
Martha Sedegah, Chad Porter, Emilie Goguet, Harini Ganeshan, Maria Belmonte, Yolanda Alcorta

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
Eric D Laing, Carol D Weiss, Emily C Samuels, Si'Ana A Coggins, Wei Wang, Yolanda Alcorta

Emerg Infect Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers.
Emilie Goguet, John H Powers, Cara H Olsen, David R Tribble, Julian Davies, Yolanda Alcorta

Open Forum Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers.
Si'Ana A Coggins, Eric D Laing, Cara H Olsen, Emilie Goguet, Matthew Moser, Yolanda Alcorta

Open Forum Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
Marvin J Sklar, Santina Maiolatesi, Noelle Patterson, Martha Sedegah, Keith Limbach, Yolanda Alcorta

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers.
Siâ Ana A Coggins, Eric D Laing, Cara H Olsen, Emilie Goguet, Matthew Moser, Yolanda Alcorta

medRxiv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
Belinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, Cara H Olsen, Simon Pollett, Yolanda Alcorta

BMC Infect Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
Bradley Hickey, Nimfa Teneza-Mora, Joanne Lumsden, Sharina Reyes, Martha Sedegah, Yolanda Alcorta

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.
Cindy Tamminga, Martha Sedegah, Santina Maiolatesi, Charlotte Fedders, Sharina Reyes, Yolanda Alcorta

Hum Vaccin Immunother· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis